Among military members, plant dermatitis can cause significant temporary disability and lost-duty time.

This case definition was developed in 2013 by the Armed Forces Health Surveillance Center (AFHSC) for the purpose of epidemiological surveillance of a sexually transmitted disease important to military associated populations.

Allergic rhinitis is a common cause of troubling symptoms and of lost-duty time associated with obtaining health care in the Armed Forces, especially during the spring and fall allergy seasons.

In the military, coccidioidomycosis is an occupational hazard for those stationed or training in endemic areas and can lead to a significant loss of workdays for those affected.

The virus that causes West Nile fever is most often spread to humans and other animals by the bite of an infected mosquito. Approximately 80% of infected individuals will have no clinical symptoms. The other 20% will have mild symptoms such as fever, headache, body aches, nausea, vomiting, swollen lymph glands, and skin rash on the chest, stomach and ...

This policy provides guidance regarding measurements and documentation of clinical outcomes in mental health treatment in military treatment facilities (MTFs).

Opinion on Appeal from the United States District Court for the District of Columbia regarding Coalition for Common Sense in Government Procurement, Appellant vs United States of America and United States Department of Defense, Appellees (No. 1:08-cv-00996)

Civilian Health and Medical Program of the Uniformed Services / TRICARE: Inclusion of TRICARE Retail Pharmacy Program in Federal Procurement of Pharmaceuticals. 32 CFR Part 199, [DOD–2008–HA–0029], RIN 0720–AB45

DEPARTMENT OF DEFENSE Office of the Secretary [DoD–2008–HA–0029; 0720–AB22] 32 CFR Part 199 Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/ TRICARE: Inclusion of TRICARE Retail Pharmacy Program in Federal Procurement of Pharmaceuticals

Summary of Memorandum Opinion issued on Nov. 30, 2009.

On January 28, 2008, Congress enacted the National Defense Authorization Act for Fiscal Year 2008 ("NDAA-08"). Section 703 of NDAA-08 requires that pharmaceuticals paid for by the Department of Defense ("Department" or "DoD") and provided through the TRICARE retail pharmacy program be subject to pricing standards known as Federal Ceiling Prices.